Search for: "MYLAN, N.V."
Results 21 - 34
of 34
Sorted by Relevance
|
Sort by Date
30 Sep 2020, 10:55 am
To illustrate the importance of drafting these risk factors carefully, consider the case where the SEC initiated an action against Mylan N.V. [read post]
7 Jul 2020, 10:55 am
To illustrate the importance of drafting these risk factors carefully, consider the case where the SEC initiated an action against Mylan N.V. [read post]
23 Dec 2009, 12:40 am
Bayer Bioscience N.V. [read post]
27 Oct 2021, 5:15 am
Mylan Laboratories Ltd. v. [read post]
27 Apr 2010, 10:58 pm
Orthofix International N.V. et al. [read post]
1 Dec 2017, 6:26 am
The recall was from Meridian Medical Technologies / Mylan N.V., affecting 13 lots of products thought to have deployment defects. [read post]
1 Dec 2017, 6:26 am
The recall was from Meridian Medical Technologies / Mylan N.V., affecting 13 lots of products thought to have deployment defects. [read post]
14 Dec 2021, 9:57 am
Janssen Pharmaceutica, N.V., No. 21-202. [read post]
15 Aug 2019, 9:05 pm
District Court for the District of Connecticut against Heritage, Mylan, Teva, and other pharmaceutical manufacturers. [read post]
26 Aug 2015, 11:02 am
Mylan also has filed another petition for inter partes review of a related patent (U.S. [read post]
17 Feb 2010, 5:10 am
(Patent Docs) Razadyne (Galantamine) / Strattera (Atomoxetine) – US: Walking the enablement/non-obviousness tightrope: Janssen Pharmaceutica N.V. v. [read post]
20 Nov 2016, 5:17 pm
For example, according to Coffee, the drug pricing scandals that have hit Valeant Pharmaceuticals and Mylan N.V. were the result of compensation schemes that as structured “incentivized” the executives at those companies to take risk. [read post]
28 Jul 2008, 7:01 pm
Innogenetics, N.V. v. [read post]
17 Mar 2020, 1:32 pm
The U.S. [read post]
